| Reporting Organization: | Gavi, The Vaccine Alliance |
|---|---|
| Total Budget ($CAD): | $ 520,000,000 |
| Timeframe: | September 17, 2015 - December 31, 2021 |
| Status: | Implementation |
| Contact Information: | Unspecified |
Gavi, The Vaccine Alliance
| Sub-Saharan Africa - $ 329,056,000.00 (63.28%) | |
|
|
|
| North Africa - $ 44,304,000.00 (8.52%) | |
|
|
|
| Southeast Asia - $ 39,156,000.00 (7.53%) | |
|
|
|
| South Asia - $ 32,032,000.00 (6.16%) | |
|
|
|
| East Asia - $ 28,496,000.00 (5.48%) | |
|
|
|
| South America - $ 20,280,000.00 (3.90%) | |
|
|
|
| Central Asia - $ 17,784,000.00 (3.42%) | |
|
|
|
| Central America - $ 8,840,000.00 (1.70%) | |
|
|
|
| Infectious & Communicable Diseases (100 %) | |
|
|
|
Gavi is an international organisation that was created in 2000 to improve access to new and underused vaccines for children living in the world’s poorest countries. Canada’s pledge to Gavi for the 2016-2020 period is a total of CAD 520 million which translates into US 409.7 million. The breakdown as follows: Canada pledged CAD 500 million to Gavi to support immunization in development countries for the period 2016-2020, more than doubling the nation’s previous total contributions. Building upon this commitment a further CAD 20 million was pledged in January 2015 and has been allocated to Gavi’s innovation accelerator, INFUSE, for Francophone Africa. This commitment makes Canada the leading donor to INFUSE- underscoring the administration’s leadership in innovation.
Canada’s support to Gavi, the Vaccine Alliance will assist in the realisation of Gavi’s Strategic Plan for 2016-2020, which aims to save 5-6 million children’s lives through equitable use of vaccines in lower income countries. Approximately 80% of these funds will be provided to procure and deliver vaccines requested by countries for their national immunizations programs. The remaining 20% of funds will be provided to countries to strengthen national health systems, including increasing health worker capacity and training and strengthening of supply and cold chain systems to support immunization programs. Gavi is a global health partnership created to address global inequities in access to new and underused vaccines.
| Gender and age: | Under-5 children Newborns |
|---|---|
| Total Direct Population: | Unspecified |
| 130,000,000 | Future deaths prevented |
| 300,000,000 | Children immunised |
| 6,000,000 | Future deaths prevented |
| 65,000,000 | Children immunised |
Canada’s support to Gavi, the Vaccine Alliance will assist in the realisation of Gavi’s Strategic Plan for 2016-2020. Full implementation of the strategy will see developing countries immunise 300 million children, saving 5–6 million lives in the long term. Coverage and equity are at the core of the strategy. Gavi’s mission is supported by four strategic goals.
(1) The vaccine goal: accelerate equitable uptake and coverage of vaccines;
(2) The systems goal: increase effectiveness and efficiency of immunisation delivery as an integrated part of strengthened health systems;
(3) The sustainability goal: improve sustainability of national immunisation programmes;
(4) The market shaping goal: shape markets for vaccines and other immunisation products.
(1) Under-5 mortality rate (2016): 60 deaths per 1,000 live births
(2) Future disability-adjusted life years averted (2017): 55 million
